A detailed history of Lri Investments, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Lri Investments, LLC holds 110 shares of BNTX stock, worth $10,969. This represents 0.0% of its overall portfolio holdings.

Number of Shares
110
Previous 167 34.13%
Holding current value
$10,969
Previous $13.4 Million 15.17%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

SELL
$78.36 - $124.66 $4,466 - $7,105
-57 Reduced 34.13%
110 $11.4 Million
Q2 2024

Jul 24, 2024

BUY
$80.36 - $102.87 $4,580 - $5,863
57 Added 51.82%
167 $13.4 Million
Q1 2024

May 21, 2024

SELL
$88.96 - $112.35 $6,316 - $7,976
-71 Reduced 39.23%
110 $10.1 Million
Q1 2024

May 14, 2024

BUY
$88.96 - $112.35 $16,101 - $20,335
181 New
181 $16.7 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $24.2B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Lri Investments, LLC Portfolio

Follow Lri Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lri Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lri Investments, LLC with notifications on news.